Jan Braess
Impact in
- Hematology top 0.5%
- Acute Myeloid Leukemia Research
- Hematopoietic Stem Cell Transplantation
- Chronic Myeloid Leukemia Treatments
- Genetics top 2%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
Papers in
- Hematology 69
- Acute Myeloid Leukemia Research 64
- Chronic Myeloid Leukemia Treatments 12
- Hematopoietic Stem Cell Transplantation 11
-
- Retinoids in leukemia and cellular processes 9
- Histone Deacetylase Inhibitors Research 8
- Co-authors
- Wolfgang Hiddemann (64 shared papers)Karsten Spiekermann (47 shared papers)Bernhard Wörmann (24 shared papers)Wolfgang E. Berdel (34 shared papers)Stefan K. Bohlander (24 shared papers)Klaus H. Metzeler (22 shared papers)Thomas Büchner (13 shared papers)Wolfgang Kern (23 shared papers)
- Journals
- Blood (22 papers)Leukemia (10 papers)Annals of Hematology (8 papers)British Journal of Haematology (6 papers)Haematologica (5 papers)
- Partner nations
- GermanyNew ZealandNetherlands
In The Last Decade
Jan Braess
93 papers receiving 2.5k citations
Peers
Comparison fields: 5 of 92
- Hematology 1.8k
- Genetics 466
- Cancer Research 273
- Public Health, Environmental and Occupational Health 426
- Molecular Biology 1.0k
Countries citing papers authored by Jan Braess
This map shows the geographic impact of Jan Braess's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Braess with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Braess more than expected).
Fields of papers citing papers by Jan Braess
This network shows the impact of papers produced by Jan Braess. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Braess. The network helps show where Jan Braess may publish in the future.
Co-authors
The 25 scholars most cited alongside Jan Braess, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 100 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 329 | |
| 2 | 2008 | 239 | |
| 3 | 2009 | 213 | |
| 4 | 2018 | 107 | |
| 5 | 2009 | 97 | |
| 6 | 2001 | 87 | |
| 7 | 2018 | 81 | |
| 8 | 2012 | 75 | |
| 9 | 2014 | 75 | |
| 10 | 2020 | 71 | |
| 11 | 2000 | 71 | |
| 12 | 2016 | 57 | |
| 13 | 2012 | 54 | |
| 14 | 2014 | 52 | |
| 15 | 2023 | 49 | |
| 16 | 2009 | 48 | |
| 17 | 2008 | 47 | |
| 18 | Oxaliplatin pharmacokinetics during a four-hour infusion. | 1999 | 46 |
| 19 | 2011 | 44 | |
| 20 | 2018 | 41 |
About Jan Braess
Jan Braess is a scholar working on Hematology, Molecular Biology, Oncology, Public Health, Environmental and Occupational Health and Genetics, having authored 100 papers that have together received 2.6k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (64 papers), Acute Lymphoblastic Leukemia research (20 papers), Chronic Myeloid Leukemia Treatments (12 papers), Hematopoietic Stem Cell Transplantation (11 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (10 papers), Retinoids in leukemia and cellular processes (9 papers), Histone Deacetylase Inhibitors Research (8 papers) and Cancer Genomics and Diagnostics (7 papers). The work is most often cited by research in Hematology (1.8k citations), Genetics (466 citations), Cancer Research (273 citations), Public Health, Environmental and Occupational Health (426 citations) and Molecular Biology (1.0k citations). Jan Braess has collaborated with scholars based in Germany, New Zealand and Netherlands. Frequent co-authors include Wolfgang Hiddemann, Karsten Spiekermann, Bernhard Wörmann, Wolfgang E. Berdel, Stefan K. Bohlander, Klaus H. Metzeler, Thomas Büchner, Wolfgang Kern, Maria‐Cristina Sauerland and Annika Dufour. Their work appears in journals such as Blood, Leukemia, Annals of Hematology, British Journal of Haematology and Haematologica.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.